Tumor factors can also activate the transcription factor Activating Transcription Factor 3 (ATF3), which suppresses the expression of cholesterol 25-hydroxylase (CH25H), thereby disrupting antigen processing and weakening cross-presentation [72]. Here, CH25H is linked to neoplasm.